A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years (ANALIA)

Bayer

Status: Completed

Conditions: Intrauterine Devices, Medicated

Treatments: Drug: Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Study type: Observational

Funder types: Industry

Identifiers

NCT02903888

18883

Details and patient eligibility

About

A cross-sectional, observational multicenter study to assess the reasons for choosing the 3-year hormonal IUD and level of IUDs knowledge among women aged 18 to 29 years. The study will be conducted in standard clinical practice conditions at public and private gynecology clinics and during a single study visit.

Approximately 1,000 women aged 18 to 29 years who have freely chosen the 3 year hormonal IUD as their contraceptive method will be included in the study.

Enrollment: 886 patients

Sex: Female

Ages: 18 to 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women aged 18 to 29 years.
• Women who decided to initiate treatment with a 3-year hormonal IUD for contraception after being adequately counseled and informed of all contraceptive options by their physician during a routine clinical visit, prior to the study visit (insertion visit).
• Women capable of reading and writing.
• Women who signed informed consent.

Exclusion criteria

• Women currently participating in an interventional clinical trial.
• Prescription of the 3-year hormonal IUD for non-contraceptive medical reasons.

Trial design

886 participants in 1 patient group

BAY86-5028

Description:

Women aged 18 to 29 years that use Jaydess for contraception

Treatment:

Drug: Levonorgestrel (Jaydess, Skyla, BAY86-5028)